Clinical Genetic Testin and Early Surgical Intervention in Patients with Multiple Endocrine Neoplasia Type 1 (MEN 1)

Annals of Surgery

Volumn 239, Issue 5, 2004, Pages 637-647

  Lairmore, Terry C ^a,b,c   Piersall, Linda D ^a   DeBenedetti, Mary K ^a   Dilley, William G ^a   Mutch, Matthew G ^a   Whelan, Alison J ^a   Zehnbauer, Barbara ^a   Hanks, John B ^c   Goldstein, Richard E ^c   Norton, Jeffrey A ^c  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c Sect of Endocr and Oncologic Surg ^*

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL TRIAL; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GENE IDENTIFICATION; GENE MUTATION; GENETIC COUNSELING; HUMAN; HYPERCALCEMIA; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MULTIPLE ENDOCRINE NEOPLASIA; PRIORITY JOURNAL; VALIDATION PROCESS; ADOLESCENT; BLOOD; CHILD; ETHICS; GENETIC PROCEDURES; GENETICS; MIDDLE AGED; MUTATION; ONSET AGE; PARATHYROIDECTOMY; PHYSIOLOGY; TUMOR SUPPRESSOR GENE;

CALCIUM; MEN1 PROTEIN, HUMAN; ONCOPROTEIN;

ADOLESCENT; ADULT; AGE OF ONSET; CALCIUM; CHILD; GENES, TUMOR SUPPRESSOR; GENETIC TECHNIQUES; GERM-LINE MUTATION; HUMANS; MALE; MIDDLE AGED; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; PARATHYROIDECTOMY; PROTO-ONCOGENE PROTEINS;

EID: 11144354699     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.sla.0000124383.98416.8d     Document Type: Article

References (24)

1. Marx S, Spiegel AM, Skarulis MC, et al. Multiple endocrine neoplasia type 1: Clinical and genetic topics. Ann Intern Med. 1998;129:484-494.
2. Ballard HS, Frame B, Hartsock RJ. Familial multiple endocrine adenoma-peptic ulcer complex. Medicine. 1964;43:481-516.
3. Wilkinson S, Teh BT, Davey KR, et al. Cause of death in multiple endocrine neoplasia type 1. Arch Surg. 1993;128:683.
4. Doherty GM, Olson JA, Frisella MM, et al. Lethality of multiple endocrine neoplasia type 1. World J Surg. 1997;22:581-586.
5. Chandrasekharappa SC, Guru SC, Manickamp P, et al. Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science. 1997;276:404-407.
6. Guru SC, Goldsmith PK, Burns AL, et al. Menin, the product of the MEN1 gene, is a nuclear protein. Proc Natl Acad Sci USA. 1998;95:1630-1634.
7. Agarwal SK, Guru SC, Heppner C, et al. Menin interacts with the AP1 transcription factor JunD and represses JunD-activated transcription. Cell. 1999;96:143-152.
8. Gobl AE, Berg M, Lopez-Egido JR, et al. Menin represses JunD-activated transcription by a histone deacetylase-dependent mechanism. Biochim Biophys Acta. 1999;1447:51-56.
9. Lemmens I, Van de Ven WJM, Kas K, et al. Identification of the multiple endocrine neoplasia type 1 (MEN1) gene. Hum Mol Genet. 1997;6:1177-1183.
10. Bassett JHD, Forbes SA, Pannett AAJ, et al. Characterization of mutations in patients with multiple endocrine neoplasia type 1. Am J Hum Genet. 1998;62:232-244.
11. Agarwal SK, Kester MB, Debelenko LV, et al. Germline mutations in the MEN1 gene in familial multiple endocrine neoplasia type 1 and related states. Hum Mol Genet. 1997;6:1169-1175.
12. Mayr B, Apenberg S, Rothamel T, et al. Menin mutations in patients with multiple endocrine neoplasia. Eur J Endocrinol. 1997;137:684-687.
13. Mutch MG, Dilley WG, Sanjurjo F, et al. Germline mutations in the multiple endocrine neoplasia type 1 gene: evidence for frequent splicing defects. Hum Mutat. 1999;13:175-185.
14. Schussheim DH, Skarulis MC, Agarwal SK, et al. Multiple endocrine neoplasia type 1: new clinical and basic findings. Trends Endocrinol Metab. 2001;12:173-178.
15. Friesen SR, Kimmel JR, Tomita T. Pancreatic polypeptide as screening marker for pancreatic polypeptide apudomas in multiple endocrinopathies. Am J Surg. 1980;139:61-72.
16. Mutch MG, Frisella MM, DeBenedetti MK, et al. Pancreatic polypeptide is a useful plasma marker for radiographically evident pancreatic islet cell tumors in patients with multiple endocrine neoplasia type 1. Surgery. 1997;122:1012-1020.
17. Lairmore TC, Chen VY, DeBenedetti MK, et al. Duodenopancreatic resections in patients with multiple endocrine neoplasia type 1. Ann Surg. 2000;231:909-918.
18. Lowney JK, Frisella MM, Lairmore TC, et al. Pancreatic islet cell tumor metastases in multiple endocrine neoplasia type 1: correlation with primary tumor size. Surgery. 1998;124:1043-1049.
19. Eriksson B, Amberg H, Lindgren P-G, et al. Neuroendocrine pancreatic tumors: clinical presentation, biochemical and histopathologic findings in 84 patients. J Intern Med. 1990;228:103-113.
20. Skogseid B, Eriksson B, Lundqvist G, et al. Multiple endocrine neoplasia type 1. A 10 year prospective screening study in four kindreds. J Clin Endocrinol Metab. 1991;73:281-287.
21. Wells SA Jr, Famdon JR, Dale JK, et al. Long-term evaluation of patients with primary parathyroid hyperplasia managed by total parathyroidectomy and heterotopic autotransplantation. Ann Surg. 1980;192:451-458.
22. Rizzoli R, Green J III, Marx SJ. Primary hyperparathyroidism in familial multiple endocrine neoplasia type 1. Long-term follow-up of serum calcium levels after parathyroidectomy. American Journal of Medicine. 1985;78:468-473.
23. Hellman P, Skogseid B, Oberg K, et al. Primary and reoperative parathyroid operations in hyperparathyroidism of multiple endocrine neoplasia type 1. Surgery. 1998;124:993-999.
24. Elaraj DM, Skarulis MC, Libutti SK, et al. Results of operation for hyperparathyroidism in patients with multiple endocrine neoplasia type 1. Surgery. 2003;134:858-865.